» Articles » PMID: 18779047

Malaria Parasite Pre-erythrocytic Stage Infection: Gliding and Hiding

Overview
Publisher Cell Press
Date 2008 Sep 10
PMID 18779047
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

In malaria, the red blood cell-infectious form of the Plasmodium parasite causes illness and the possible death of infected hosts. The initial infection in the liver caused by the mosquito-borne sporozoite parasite stage, however, causes little pathology and no symptoms. Nevertheless, pre-erythrocytic parasite stages are attracting passionate research efforts not least because they are the most promising targets for malaria vaccine development. Here, we review how the infectious sporozoite makes its way to the liver and subsequently develops within hepatocytes. We discuss the factors, both parasite and host, involved in the interactions that occur during this "silent" phase of infection.

Citing Articles

A Head-to-Head Comparative Study of the Replication-Competent Vaccinia Virus and AAV1-Based Malaria Vaccine versus RTS,S/AS01 in Murine Models.

Zainal K, Hasyim A, Yamamoto Y, Mizuno T, Sato Y, Rasyid S Vaccines (Basel). 2024; 12(10).

PMID: 39460322 PMC: 11512279. DOI: 10.3390/vaccines12101155.


A Review of Major Patents on Potential Malaria Vaccine Targets.

Mariano R, Goncalves A, Oliveira D, Ribeiro H, Pereira D, Santos I Pathogens. 2023; 12(2).

PMID: 36839519 PMC: 9959516. DOI: 10.3390/pathogens12020247.


Hijacking the human complement inhibitor C4b-binding protein by the sporozoite stage of the parasite.

Khattab A, Rezola M, Barroso M, Kyrklund M, Pihlajamaa T, Freitag T Front Immunol. 2022; 13:1051161.

PMID: 36479121 PMC: 9720182. DOI: 10.3389/fimmu.2022.1051161.


Subcutaneous Immunization with Unaltered Axenic Malaria Parasite Liver Stages Induces Sterile Protection against Infectious Sporozoite Challenge.

Kamil M, Deveci G, Kina U, Kappe S, Aly A Vaccines (Basel). 2022; 10(11).

PMID: 36366392 PMC: 9695791. DOI: 10.3390/vaccines10111884.


Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.

Owoloye A, Ligali F, Enejoh O, Musa A, Aina O, Idowu E PLoS One. 2022; 17(8):e0268269.

PMID: 36026508 PMC: 9417013. DOI: 10.1371/journal.pone.0268269.


References
1.
Matuschewski K . Getting infectious: formation and maturation of Plasmodium sporozoites in the Anopheles vector. Cell Microbiol. 2006; 8(10):1547-56. DOI: 10.1111/j.1462-5822.2006.00778.x. View

2.
Carrolo M, Giordano S, Cabrita-Santos L, Corso S, Vigario A, Silva S . Hepatocyte growth factor and its receptor are required for malaria infection. Nat Med. 2003; 9(11):1363-9. DOI: 10.1038/nm947. View

3.
Cowman A, Crabb B . Invasion of red blood cells by malaria parasites. Cell. 2006; 124(4):755-66. DOI: 10.1016/j.cell.2006.02.006. View

4.
Mueller A, Camargo N, Kaiser K, Andorfer C, Frevert U, Matuschewski K . Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci U S A. 2005; 102(8):3022-7. PMC: 548321. DOI: 10.1073/pnas.0408442102. View

5.
Yalaoui S, Zougbede S, Charrin S, Silvie O, Arduise C, Farhati K . Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain. PLoS Pathog. 2008; 4(2):e1000010. PMC: 2279262. DOI: 10.1371/journal.ppat.1000010. View